EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Follow‐up post‐ HCV virological response to DAA in advanced chronic liver disease

A Romano iD, N Zeni, A R Caspanello, S Phillips, S S Piano iD, P Angeli

Liver International · 2024

DOI: 10.1111/liv.16113 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, 2024. Verfasst von A Romano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Sustained Virologic Response, Hepatitis C, Chronic, Disease Progression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Direct‐acting antivirals (DAA) achieve high virological response rates with minimal side effects for many patients. Despite their significant impact on the progression and epidemiology of hepatitis C virus (HCV) associated liver disease, the global annual incidence of chronic infections is expected to remain relatively constant, averaging 1.42 million new cases each year until 2030. Furthermore, by 2030, there will be a 14–17% increase in end‐stage liver disease outcomes such as liver‐related deaths, hepatocellular carcinoma (HCC), and decompensated cirrhosis in adults aged 18 years and over. Although reductions in liver decompensation, HCC occurrence, and mortality have been shown in patients with advanced liver disease who achieved sustained virological response (SVR) with DAA, these benefits may be less significant in those with decompensated liver cirrhosis. This review aims to summarise the impact of the virological response to DAA on liver disease progression and outcomes in patients with advanced chronic liver disease, which appears to be crucial for defining patient‐specific follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSustained Virologic ResponseHepatitis C, ChronicDisease ProgressionLiver CirrhosisHepacivirusLiver NeoplasmsCarcinoma, HepatocellularHumans

Stichwörter der Autor:innen

advanced chronic liver diseasechronic hepatitis Csustained virological response

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padova, Italy.
  • Department of Clinical and Experimental Medicine, Unit of Medicine and Hepatology, University of Messina, Messina, Italy.
  • Institute of Hepatology Foundation for Liver Research London UK, School of Immunology and Microbial Sciences King's College London, London, UK.

ORCID-Profile: A Romano, S S Piano

Zitieren

APA

Romano, A., Zeni, N., Caspanello, A. R., Phillips, S., Piano, S. S., & Angeli, P. (2024). Follow‐up post‐ HCV virological response to DAA in advanced chronic liver disease. Liver International. https://doi.org/10.1111/liv.16113

Vancouver

Romano A, Zeni N, Caspanello AR, Phillips S, Piano SS, Angeli P. Follow‐up post‐ HCV virological response to DAA in advanced chronic liver disease. Liver International. 2024. doi:10.1111/liv.16113

BibTeX
@article{Romano2024,
  author = {Romano, A and Zeni, N and Caspanello, A R and Phillips, S and Piano, S S and Angeli, P},
  title = {Follow‐up post‐ HCV virological response to DAA in advanced chronic liver disease},
  journal = {Liver International},
  year = {2024},
  doi = {10.1111/liv.16113}
}
Kostenlos starten →